Polydatin, a nutraceutical agent, reduces cardiotoxicity and enhances the anticancer effects of Sunitinib through the reduction of lipid peroxidation and expression of NLRP3 inflammasome

29 June 2021 (08:00 - 23:59)
Organised by:
Congress Presentation Part of: ePoster session Cardio-Oncology HFA Premium Access Heart Failure 2021